ATS2017 5月21日



<5月21日> News1~News22

・A845- J. McKinnell, et al. Clinical Predictors of Antibiotic Failure in Adult Outpatients with Community-Acquired Pneumonia
・A5060 -K. M. Kunisaki, et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Increase Subsequent Cardiovascular Event Risk: A Secondary Analysis of Adjudicated SUMMIT Study Data
・A1033 - Z. Chen, et al. Increased Physical Activity Associated with Decreased IL-6 and CRP in Patients with COPD.
・A1193 - L. P. Hayden, et al. Childhood Pneumonia Is a Risk Factor for COPD Development but Not Progression in the COPDGene Study
・A8674 - A.A. Diaz, et al. Low Muscle Mass and Mortality in Smokers with and Without COPD
・A6524 - M. Dres, et al. Effect of High Volume ICUs on Mortality in ARDS Over 15 Years.
・A1660 -S. Nuguru, et al. Safety and Efficacy of Endobronchial Ultrasound Guided Transvascular Needle Aspiration(EBUS-TVNA)
・A7408 - J. Hetzel, et al. Bleeding Severity After Transbronchial Cryobiopsies Is Influenced by Body Height and Age
・Patrick B. Murphy, et al. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD ExacerbationA Randomized Clinical Trial. JAMA. Published online May 21, 2017. (JAMA掲載)
・A1119 -A. Brueder, et al. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: Diagnostic Yield, Outcomes and Risk Factors for Complications
・A5304 -J.L. Salinas, et al. Factors Associated with Mortality Among Patients with Multidrug-Resistant Tuberculosis--United States, 1993-2013
・A1121 -Z. Hu, et al. Six-Minute-Walk Test (6MWT) and Pulmonary Function in Interstitial Lung Disease (ILD) Patients
・A2846 -S. A. Guler, et al. Prevalence and Predictors of Sarcopenia in Fibrotic Interstitial Lung Disease
・A2672 -J. A. Smith, et al. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Anti-Tussive Therapy for Chronic Refractory Cough: Results from a Phase 2 Study (VOLCANO-1)
・A2671 - J. Cheng, et al. Severity, Predictors, and Impact of Cough in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
・A2733 - G. G. Paul, et al. Lower Serum IgA Is Associated with COPD Exacerbation Risk: SPIROMICS and COPDGene
・A1333 - I. Strambu, et al. Treatment of Acute Exacerbations in COPD: An Exploratory Phase II Study of Single and Repeated Doses of Acumapimod (BCT197), an Oral p38 Inhibitor
・A7570 - E. M. Hessel,, et al. Safety, Pharmacokinetics and Dose-response Characteristics of GSK2269557, an Inhaled PI3Kδ Inhibitor Under Development for the Treatment of COPD
・Christopher W. Seymour, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. NEJM May 21, 2017DOI: 10.1056/NEJMoa1703058 (NEJM掲載)

by otowelt | 2017-05-22 23:03 | 呼吸器その他

<< ATS2017 5月22日 ATS2017開幕:速報ページ... >>